Drug intelligence / Profile preview

chitosan + selenium nanoparticles + olive oil

Development stage
Preclinical
Lead developer
Al Jouf University
Modality
Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

The chitosan + selenium nanoparticles + olive oil nanocomplex (CS/SeNPs@Jouf Oo) is a novel anticancer therapeutic agent comprising environmentally biodegradable chitosan (CS), selenium nanoparticles (SeNPs), and Jouf olive oil (Jouf Oo). This nanocomposite, characterized by a nanostructure of approximately 95 nm and high thermal stability, is designed to provide a safer and more targeted alternative to traditional chemotherapies like doxorubicin. Its mechanism of action involves the induction of apoptosis in cancer cells through the modulation of key oncogenes and tumor suppressors, specifically the downregulation of anti-apoptotic BCL2 and the cell cycle regulator P21, alongside the upregulation of the tumor suppressor p53 and the pro-inflammatory cytokine TNF. Preclinical studies have demonstrated its efficacy against human colorectal adenocarcinoma (Caco2), hepatocellular carcinoma (HepG2), and breast cancer (MCF7) cell lines, showing a four-fold increase in targeting cancer cells compared to normal cells.

Other names
Chitosan/Selenium@Olive Oil NanocomplexCS/SeNPs@Jouf Oo nanocomplex
02

Targets

BCL-2 (BCL-2 family)CDKN1A (Cyclin-dependent kinase inhibitor 1A)TP53 (Cellular Tumor Antigen p53 R175H)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on chitosan + selenium nanoparticles + olive oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chitosan + selenium nanoparticles + olive oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call